FDA Warns of Rare Vision Loss Risk in GLP-1 Weight Loss Drugs @NEWSCENTERMaine
FDA Warns of Rare Vision Loss Risk in GLP-1 Weight Loss Drugs  @NEWSCENTERMaine
Uploaded November 2026 | Updated November 2026, 3 days ago
The FDA announced a new warning on GLP-1 weight loss drugs, cautioning about a rare risk of vision loss connected to decreased blood flow to the optic nerve.
FDA Warns of Rare Vision Loss Risk in GLP-1 Weight Loss DrugsPortland rushes to hire staff for emergency warming shelterMainers see surge in oil pricesBrunswick police officer accused of using excessive force against teenBates College first to admit women: why access didnt mean equalityMaine sets another record for Lyme Disease casesTariffs: How Trumps plan to tax imports could impact MainersVeterans Day detours set to affect Portland Metro routesKennebunk Fire shares water safety reminders after child near-drowningMaine lawmakers response to Robbins Lumber explosionDriver crashes into building behind Falmouth bakeryLarge water leak causes damage at Falmouth nursing facility
NEWS CENTER Maine |

FDA Warns of Rare Vision Loss Risk in GLP-1 Weight Loss Drugs

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER